Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-14
2011-06-14
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S567000
Reexamination Certificate
active
07960375
ABSTRACT:
The invention relates to new 8-chloro-2,3-benzodiazepine derivatives of the general formula (I), wherein R stands for a lower alkyl group or a group of the general formula —NH—R′, wherein R′ stands for a lower alkyl or a lower cycloalkyl group), and pharmaceutically acceptable acid addition salts thereof. The invention also encompasses a process for the preparation of said compounds, pharmaceutical compositions containing them and new intermediates useful for the preparation of the new 8-chloro-2,3-benzodiazepine derivatives. The compounds according to the invention possess AMPA/kainate receptor inhibiting activity.
REFERENCES:
patent: 4322346 (1982-03-01), Korosi et al.
patent: 4614740 (1986-09-01), Lang et al.
patent: 4840948 (1989-06-01), Lang et al.
patent: 6200970 (2001-03-01), Ling et al.
patent: 2566774 (1986-01-01), None
patent: WO 9211262 (1992-07-01), None
Barkoczy Jozsef
Gigler Gabor
Harsing Laszlo Gabor
Kertész Szabolcs
Ling Istvan
Coleman Brenda L
Egis Gyogyszergyar Rt.
Myers Jonathan
Wilford Andrew
LandOfFree
8-chloro-2,3-benzodiazepine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-chloro-2,3-benzodiazepine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-chloro-2,3-benzodiazepine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639784